Synopsis
Synopsis
0
KDMF
0
VMF
0
FDF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4,4'-(2-picolylidene)bisphenylsulfuric Acid
2. 4,4'-(picoliliden)-bis-phenylsulphate
3. Laxoberal
4. Picolax
5. Picoprep
6. Picosulfate Sodium
7. Picosulfol
1. 10040-45-6
2. Picosulfate Sodium
3. Laxoberal
4. Laxoberon
5. Sodium Picosulphate
6. Evacuol
7. Picolax
8. Neopax
9. Guttalax-fher
10. Pico-salax
11. Da-1773
12. 4,4'-(2-picolylidene)bis(phenylsulfuric Acid) Disodium Salt
13. La 391
14. Picosulfate Sodium Anhydrous
15. Sodium Picosulfate Anhydrous
16. Anhydrous Sodium Picosulfate
17. Da 1773
18. Sodium Picosulphate Anhydrous
19. Picosulfol
20. Guttalax
21. Rapilax
22. Chebi:32147
23. 4,4'-(2-pyridylmethylene)diphenol Bis(hydrogen Sulfate) Disodium Salt
24. Vw106606y8
25. Laxidogol
26. Evanol
27. Disodium;[4-[pyridin-2-yl-(4-sulfonatooxyphenyl)methyl]phenyl] Sulfate
28. Sodium Picosulfate 100 Microg/ml In Acetonitrile
29. Picosulfate Sodium Hydrate
30. Picoprep
31. Natrii Picosulfas
32. Sodium Picosulphate Monohydrate
33. Picosulfato Sodico
34. Disodium 4,4'-(2-pyridylmethylene)-di(phenyl Sulphate);disodium 4,4'-(2-pyridylmethylene)-di(phenyl Sulphate);sodium Picosulfate
35. Natrii Picosulfas [inn-latin]
36. Picosulfate De Sodium
37. La-391
38. Picosulfato Sodico [inn-spanish]
39. Ncgc00182711-01
40. Picosulfate De Sodium [inn-french]
41. Sodium Picosulfate [inn:ban:jan]
42. Einecs 233-120-9
43. 2-picolylidenebis(p-phenyl Sodium Sulfate)
44. Natriumpicosulfat
45. Unii-vw106606y8
46. Guttalax;laxoberon
47. Disodium 4,4'-disulfoxydiphenyl-(2-pyridyl)methane
48. Bisacodyl Impurity D
49. 4-methyl-2-pentenoicacid
50. 4,4'-(2-pyridylmethylene)diphenolbis(hydrogen Sulfate) (ester) Disodium Salt
51. 4,4'-(2-pyridinylmethylene)bisphenol Bis(hydrogen Sulfate) (ester) Disodium Salt
52. Dsstox_cid_28589
53. Dsstox_rid_82860
54. Dsstox_gsid_48663
55. Schembl346436
56. Picosulfate Sodium [mi]
57. Chembl1697768
58. Dtxsid7048663
59. Sodium Picosulfate [inn]
60. Picosulfate For System Suitability
61. Hms3652k17
62. Bcp11522
63. Tox21_113026
64. Mfcd00867640
65. S4020
66. 4,4'-(2-pyridinylmethylene)bisphenol 1,1'-bis(hydrogen Sulfate) Sodium Salt
67. Phenol, 4,4'-(2-pyridylmethylene)bis-, Bis(hydrogen Sulfate), Disodium Salt
68. Ccg-269559
69. Ac-31735
70. As-15785
71. Cas-10040-45-6
72. Ft-0673898
73. S0936
74. Sw219183-1
75. C71029
76. Q410265
77. Sodium (pyridin-2-ylmethylene)bis(4,1-phenylene) Bis(sulfate)
78. Sodium 4,4'-(pyridin-2-ylmethylene)bis(4,1-phenylene) Disulfate
79. 4,4'-(2-pyridylmethylene)diphenol Bis(hydrogen Sulphate) Disodium Salt
| Molecular Weight | 481.4 g/mol |
|---|---|
| Molecular Formula | C18H13NNa2O8S2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 480.98779728 g/mol |
| Monoisotopic Mass | 480.98779728 g/mol |
| Topological Polar Surface Area | 163 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 633 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Cathartics
Agents that are used to stimulate evacuation of the bowels. (See all compounds classified as Cathartics.)
A - Alimentary tract and metabolism
A06 - Drugs for constipation
A06A - Drugs for constipation
A06AB - Contact laxatives
A06AB08 - Sodium picosulfate
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23477
Submission : 2010-01-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-06
Pay. Date : 2013-11-15
DMF Number : 27646
Submission : 2013-10-17
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27627
Submission : 2013-10-08
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Certificate Number : R1-CEP 2003-068 - Rev 00
Status : Valid
Issue Date : 2009-11-04
Type : Chemical
Substance Number : 1031
Certificate Number : CEP 2020-021 - Rev 02
Status : Valid
Issue Date : 2024-07-15
Type : Chemical
Substance Number : 1031
Certificate Number : CEP 2014-020 - Rev 02
Status : Valid
Issue Date : 2024-09-20
Type : Chemical
Substance Number : 1031
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
About the Company : Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in th...
Jai Radhe Sales is your partner for all your sourcing needs.
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to m...
About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...
About the Company : We are a renowned pharma player having a wide range of quality products and specialise in manufacturing Active Pharmaceutical Ingredients (API) and Drug Intermediates (DI’s). The...
About the Company : Indian Pharmaceutical Company, Precise Group is emerging as a global player in several verticals in healthcare. The Mumbai based drug manufacturing company’s strength lies in a s...
About the Company : Rakshit is an integrated API manufacturing company. Established in 2000. Today Rakshit has emerged a dependable and strong manufacturer of key APIs & intermediates for global marke...
About the Company : Shreepati Pharmaceuticals is an ISO-9001 : 2015 and GMP certified company. We are a leading manufacturer and exporter of raw materials for the pharmaceutical industry. Our range i...
About the Company : Adapting quickly to the ever-evolving demands, we have emerged as one of the fastest growing organization in the pharmaceutical industry across the globe. With our headquarters loc...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
Details:
The company has signed an agreement to acquire five legacy brands are Piclin, Menoctyl (Otilonium Bromide), Sucramal O (Sucralfate + Oxetacaine), Pyridium (Phenazopyridine) and Distaclor (Cefaclor) catering to gastroenterology, urology and anti-infective segments.
Lead Product(s): Sodium Picosulfate
Therapeutic Area: Gastroenterology Brand Name: Piclin
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Lupin Ltd
Deal Size: $12.1 million Upfront Cash: Undisclosed
Deal Type: Acquisition September 22, 2023
Lead Product(s) : Sodium Picosulfate
Therapeutic Area : Gastroenterology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Lupin Ltd
Deal Size : $12.1 million
Deal Type : Acquisition
Lupin Inks Pact to Acquire 5 Drug Brands from Menarini for Rs 101 Crore
Details : The company has signed an agreement to acquire five legacy brands are Piclin, Menoctyl (Otilonium Bromide), Sucramal O (Sucralfate + Oxetacaine), Pyridium (Phenazopyridine) and Distaclor (Cefaclor) catering to gastroenterology, urology and anti-infective...
Brand Name : Piclin
Molecule Type : Small molecule
Upfront Cash : Undisclosed
September 22, 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info : Generic
Registration Country : Pakistan
Brand Name : Laxacos
Dosage Form : SYRUP
Dosage Strength : 5MG
Packaging : 60ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Pakistan
Regulatory Info :
Registration Country : Sweden
Sodium picosulfate (monohydrate)
Brand Name : Laxoberal
Dosage Form : SOFT CAPSULE
Dosage Strength : 2.5 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Ukraine
Brand Name : Picolax
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Regulatory Info : RX
Registration Country : USA
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
Brand Name : CLENPIQ
Dosage Form : SOLUTION;ORAL
Dosage Strength : 12GM/BOT;3.5GM/BOT;10MG/BOT
Packaging :
Approval Date : 2017-11-28
Application Number : 209589
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Sodium picosulfate (monohydrate)
Brand Name : Cilaxoral
Dosage Form : ORAL DROPS, SOLUTION
Dosage Strength : 7.5 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Several substances refer to content
Brand Name : PICOLAX
Dosage Form : POWDER FOR ORAL SOLUTION
Dosage Strength : -
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info : Generic
Registration Country : South Korea
Brand Name :
Dosage Form : POWDER
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Regulatory Info :
Registration Country : South Korea
Brand Name : Chemlight Powder
Dosage Form : Powder
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Regulatory Info : Ethical
Registration Country : Canada
Brand Name : PURG-ODAN
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 10MG/SACHET
Packaging : 2/1 SACHETS
Approval Date :
Application Number : 2317966
Regulatory Info : Ethical
Registration Country : Canada
Regulatory Info :
Registration Country : Switzerland
Sodium picosulphate; magnesium oxidate; citric acid anhydrous
Brand Name : CitraFleet
Dosage Form : Plv
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - FOR SOLUTION;ORAL - 12GM/PACKET;3.5G...DOSAGE - FOR SOLUTION;ORAL - 12GM/PACKET;3.5GM/PACKET;10MG/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 202535
DOSAGE - SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;1...DOSAGE - SOLUTION;ORAL - 12GM/BOT;3.5GM/BOT;10MG/BOT
USFDA APPLICATION NUMBER - 209589
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
US Patents
Patent Expiration Date : 2034-06-26
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
US Patent Number : 9827231
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209589
Patent Use Code : U-2162
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-26
Patent Expiration Date : 2034-06-23
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
US Patent Number : 11191753
Drug Substance Claim :
Drug Product Claim :
Application Number : 209589
Patent Use Code : U-3261
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-23
Patent Expiration Date : 2028-10-10
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
US Patent Number : 8450338
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202535
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-10-10
Patent Expiration Date : 2034-06-23
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
US Patent Number : 10624879
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209589
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-06-23
Patent Expiration Date : 2028-10-10
CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE
US Patent Number : 8481083
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202535
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-10-10
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
EDQM
Picosulfate for system suitability
CAS Number : 10040-45-6
Quantity Per Vial : 0.5 mg
Sale Unit : 1
Order Code : Y0001104
Batch No : 2
Price (€) : 79
Storage : +5°C ± 3°C
CAS Number : 10040-45-6
Quantity Per Vial : 50 mg
Sale Unit : 1
Order Code : S0785000
Batch No : 2
Price (€) : 79
Storage : +5°C ± 3°C
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]USP
CAS Number : 10040-45-6
Quantity Per Vial :
Price ($) : 230
Catalog Number : 1614578
Current Lot : F0I074
Previous Lot :
NDC Code :
Sodium Picosulfate Related Compound A (20 mg)...
CAS Number : 32500-19-9
Quantity Per Vial :
Price ($) : 730
Catalog Number : 1614589
Current Lot : R065L0
Previous Lot : F0I228 (30-APR-2018)
NDC Code :
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
